PP
RMD icon

Pacifica Partners’s ResMed RMD Stock Holding History

Pacifica Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40
Closed -$7.72K – 560
2024
Q1 		$7.72K Hold
40
– – ﹤0.01% 387
2023
Q4 		$6.44K Hold
40
– – ﹤0.01% 409
2023
Q3 		$5.82K Hold
40
– – ﹤0.01% 399
2023
Q2 		$8.65K Sell
40
-30
-43% -$6.69K ﹤0.01% 317
2023
Q1 		$15.5K Hold
70
– – 0.01% 266
2022
Q4 		$14.5K Buy
+70
New +$15.4K 0.01% 252

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacifica Partners's RMD Position: Q2 2024 in Review

Pacifica Partners sold out of ResMed (RMD) in Q2 2024, closing a stake of 40 shares — an estimated $7.72K sold.

Pacifica Partners first reported a position in RMD in Q4 2022 and held it in 6 quarters. The position peaked at $15.5K in Q1 2023. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Pacifica Partners reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Pacifica Partners sold 40 ResMed shares in Q2 2024, an estimated $7.72K.
  • Pacifica Partners first reported a position in ResMed in Q4 2022 and held it in 6 quarters.
  • Pacifica Partners's ResMed position peaked at $15.5K in Q1 2023.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Pacifica Partners's 13F filing for Q2 2024, filed 11 Jul 2024.